138 related articles for article (PubMed ID: 29147213)
1. Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis.
Kono T; Satomi M; Chisato N; Ebisawa Y; Suno M; Asama T; Karasaki H; Matsubara K; Furukawa H
World J Oncol; 2010 Dec; 1(6):232-235. PubMed ID: 29147213
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
[TBL] [Abstract][Full Text] [Related]
4. Effects of Topical Hangeshashinto (TJ-14) on Chemotherapy-Induced Oral Mucositis.
Ozawa N; Onda T; Hayashi K; Honda H; Shibahara T
Cancer Manag Res; 2020; 12():1069-1078. PubMed ID: 32104087
[TBL] [Abstract][Full Text] [Related]
5. The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).
Nishikawa K; Aoyama T; Oba MS; Yoshikawa T; Matsuda C; Munemoto Y; Takiguchi N; Tanabe K; Nagata N; Imano M; Oshiro M; Fukushima R; Kataoka M; Morita S; Tsuburaya A; Mishima H; Kono T; Sakamoto J
J Cancer; 2018; 9(10):1725-1730. PubMed ID: 29805697
[No Abstract] [Full Text] [Related]
6. The effect of Hangeshashinto on Oral Mucositis Caused by Induction Chemotherapy in Patients with Head and Neck Cancer.
Taira K; Fujiwara K; Fukuhara T; Koyama S; Takeuchi H
Yonago Acta Med; 2020 Aug; 63(3):183-187. PubMed ID: 32884437
[TBL] [Abstract][Full Text] [Related]
7. Hangeshashinto (TJ-14) prevents radiation-induced mucositis by suppressing cyclooxygenase-2 expression and chemotaxis of inflammatory cells.
Kamide D; Yamashita T; Araki K; Tomifuji M; Shiotani A
Clin Transl Oncol; 2017 Nov; 19(11):1329-1336. PubMed ID: 28516399
[TBL] [Abstract][Full Text] [Related]
8. A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.
Yamashita T; Araki K; Tomifuji M; Kamide D; Tanaka Y; Shiotani A
Support Care Cancer; 2015 Jan; 23(1):29-35. PubMed ID: 24943276
[TBL] [Abstract][Full Text] [Related]
9. Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis.
Ogihara T; Kagawa M; Yamanaka R; Imai S; Itohara K; Hira D; Nakagawa S; Yonezawa A; Ito M; Nakagawa T; Terada T; Matsubara K
J Nat Med; 2023 Jan; 77(1):53-63. PubMed ID: 36002763
[TBL] [Abstract][Full Text] [Related]
10. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.
Hejna M; Köstler WJ; Raderer M; Steger GG; Brodowicz T; Scheithauer W; Wiltschke C; Zielinski CC
Eur J Cancer; 2001 Nov; 37(16):1994-2002. PubMed ID: 11597376
[TBL] [Abstract][Full Text] [Related]
11. Hangeshashinto improves the completion rate of chemoradiotherapy and the nutritional status in patients with head and neck cancer.
Hatakeyama H; Takahashi H; Oridate N; Kuramoto R; Fujiwara K; Homma A; Takeda H; Fukuda S
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):100-8. PubMed ID: 25896416
[TBL] [Abstract][Full Text] [Related]
12. Pain mechanism of oral ulcerative mucositis and the therapeutic traditional herbal medicine hangeshashinto.
Hitomi S; Ujihara I; Ono K
J Oral Biosci; 2019 Mar; 61(1):12-15. PubMed ID: 30929796
[TBL] [Abstract][Full Text] [Related]
13. Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study.
Lalla RV; Pilbeam CC; Walsh SJ; Sonis ST; Keefe DM; Peterson DE
Support Care Cancer; 2010 Jan; 18(1):95-103. PubMed ID: 19404685
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer.
Miyashita T; Kono T; Matsui D; Yamazaki Y; Sadatomi D; Fujitsuka N; Nakanuma S; Okamoto K; Makino I; Kinoshita J; Nakamura K; Oyama K; Tajima H; Takamura H; Ninomiya I; Fushida S; Mukaisho K; Harmon JW; Ohta T
Surgery; 2018 Mar; ():. PubMed ID: 29576309
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Topical Application of Honey on Oral Mucosa of Children for the Management of Oral Mucositis Associated with Chemotherapy.
Singh R; Sharma S; Kaur S; Medhi B; Trehan A; Bijarania SK
Indian J Pediatr; 2019 Mar; 86(3):224-228. PubMed ID: 30084098
[TBL] [Abstract][Full Text] [Related]
16. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
[TBL] [Abstract][Full Text] [Related]
17. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.
Ibrahim EM; al-Mulhim FA
Med Oncol; 1997 Mar; 14(1):47-51. PubMed ID: 9232612
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
19. Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.
Cook A; Modh A; Ali H; Sheqwara J; Chang S; Ghanem T; Momin S; Wu V; Tam S; Money S; Han X; Fakhoury L; Movsas B; Siddiqui F
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):926-937. PubMed ID: 34808255
[TBL] [Abstract][Full Text] [Related]
20. The traditional Japanese medicine hangeshashinto alleviates oral ulcer-induced pain in a rat model.
Hitomi S; Ono K; Yamaguchi K; Terawaki K; Imai R; Kubota K; Omiya Y; Hattori T; Kase Y; Inenaga K
Arch Oral Biol; 2016 Jun; 66():30-7. PubMed ID: 26878477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
